CD4 and neoplasm: A recent study in Classic Hodgkin lymphoma (CHL) murine models demonstrated that PD-1 blockade therapy has strong anti-tumor effects on MHC-II expressing tumors mediated by cytotoxic CD4+ T cells (77).